1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News MARCH 2015

Respiratory Therapy News MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 15 pages

Industry Trend Analysis - Anti-PD1 Race Continues Despite BMS' NSCLC Approval Win
Industry Trend Analysis - Ruthigen Reverse Merger To Boost Pulmatrix' Respiratory Product Development
Industry Brief - AstraZeneca Completes Purchase Of Actavis' Branded Respiratory Assets
Industry Brief - Sunovion Initiates SUN-101/eFlow Phase III Trial Programme In COPD
Industry Brief - Merrimack Initiates Biomarker-Selected MM-121 Phase II Trial
Industry Brief - AeroVanc Phase II Trial Meets Primary Endpoint Of MRSA Reduction In CF
Industry Brief - AirFluSal Forspiro Launched In Portugal/Ireland
Industry Brief - Positive Results From AstraZeneca's PT003 COPD Programme
Industry Brief - Combination Cell-Gene Therapy For LC To Be Tested In UK Patients
Industry Brief - Biota Commences Dosing In Vapendavir Phase IIb Trial For Asthma
Industry Brief - Coronado/NeuPharma To Co-Develop Covalent Third-Generation EGFr Inhibitors
Industry Brief - Dako/Ono To Co-Develop PD-1 Companion Diagnostic For Opdivo
Industry Brief - FDA Accepts Rapamune sNDA For Priority Review In LAM
Industry Brief - OSE Pharma Launches IPO On Euronext Paris
Industry Brief - Bayer's Adempas Approved In Japan For PAH
Industry Brief - Eisai's Lenvatinib Extends OS In Phase II NSCLC Trial
Industry Brief - Abraxane Gains EU Approval For First-Line NSCLC
Industry Trend Analysis - Opdivo Set To Become First PD-1 Inhibitor On NSCLC Market Ahead Of Keytruda
Industry Brief - Actelion's NDA For Uptravi Accepted By FDA With Standard Review Time
Industry Brief - Kalydeco Gains FDA Approval For Expanded Age Range
Industry Brief - Zykadia Gains CHMP Positive Opinion For ALK+ NSCLC Previously Treated With Crizotinib
Industry Brief - N30 Pharmaceuticals Changes Name To Nivalis Therapeutics
Industry Brief - Takeda Acquires Select Portfolio From Neutec
Industry Brief - ACD's RNAscope Technology Supports Merrimack's MM-121 Phase II Trial
Industry Brief - Jubilant Gains New US Product Approvals
Industry Brief - Aeolus' AEOL 10150 Gains FDA ODD For IPF
Industry Trend Analysis - J&J Will Still Reap Potential Rewards From Galapagos' IPF Candidate
Industry Brief - FDA Grants ODD To Selten's Tacrolimus For PAH

Table Of Contents

Respiratory Therapy News MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.